The global new born eye imaging systems market is forecasted to be valued at US$ 374.3 million by 2032, up from US$ 202.7 million in 2022, advancing at a CAGR of 5.7% during the forecast period.
Report Attribute | Details |
---|---|
New Born Eye Imaging Systems Market Value (2022) | US$ 202.7 Million |
New Born Eye Imaging Systems Market Anticipated Value (2032) | US$ 374.3 Million |
New Born Eye Imaging Systems Projected Growth Rate (2022 to 2032) | 5.7% |
The eye imaging system is a type of device that helps in recognizing eye-related problems.
The demand for newborn eye imaging systems is increasing because a huge number of people are suffering from various eye disorders has increased considerably. The new born babies also undergo eye problems such as retinopathy of prematurity (ROP) which may result in the loss of eyesight and affects the blood cells.
Therefore, it is anticipated that the new born eye imaging systems is likely to witness significant growth during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
It is projected that there is a rapid rise in the number of babies that are suffering from eye problems across the world, and it is serving to be one of the primary factors driving the growth and demand for the new born eye imaging systems.
The newborn eye imaging systems are highly adopted because it works on a simple process, and the tool is used for the identification of the problem for treatment.
Moreover, in newborn babies, the ROP (Retinopathy of Prematurity) is the main reason for vision loss; ROP also affects the blood vessels and spreads via the retina, which is fueling the demand in the new born eye imaging systems market.
Furthermore, the ratio of affected-born babies is likely to fuel the market to come up with more advanced products in the market.
In addition to that, it is anticipated that there is a rapidly increasing approval for the new born eye imaging systems from the respective organizations and rapid technological advancements by various market players, which is further accelerating the expansion of the new born eye imaging systems market size and are also offering significant growth opportunities for the mareket during the forecast period of 2022-2032.
It is anticipated that there is very less awareness about the new born eye imaging systems in the market, which is likely to hinder the growth of this product market.
In addition to that, there is a high cost involved in the usage of new born eye imaging systems. One of the key restraining factors that are to curb the growth of the new born eye imaging market is the dearth of trained professionals.
Furthermore, there is increasing adoption of refurbished imaging systems that have the potential to challenge the growth of the new born eye imaging systems and influence the market share for new born eye imaging systems.
It is projected that North American regions are likely to lead the new born eye imaging systems market. It is currently accountable for 35.8% of the total new born eye imaging systems market share.
The growth of the new born eye imaging systems market is owing to the strong presence of the major market players in this region.
Furthermore, there is an increasing number of new born population that is suffering from eye problems in this region, and are looking for minimally invasive procedures to overcome the issues. It has been revealed, for instance, according to Centers for Disease Control and Prevention in October 2016, one in every 33 babies is affected from eye borne diseases.
Europe is anticipated to follow North America, and is currently accountable for 25.3% of the total market share for new born eye imaging systems market.
The market in European regions has the potential to influence the global new born eye imaging systems market as the government of this region is directly involved in the treatment of eye diseases, hence leading to significant growth of the market size in the upcoming years.
The start-up ecosystem in the new born eye imaging systems market is intense with frequent innovations being made. Start-ups in the new born eye imaging systems market are focusing on improvising the tools for better implementation of devices in the new born populace.
The Palo Alto startup has developed an AI-based system that can screen the retinal images of newborn babies to highlight potential eye conditions that require follow-up and treatment.
Remido Innovative Solutions is another start-up providing cures to new born babies. Remidio is developing more sophisticated devices to revolutionize the new born eye imaging systems market and fuel the growth further during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the biggies in the new born eye imaging systems market include ;D-EYE S.r.l., Natus Medical Incorporated, SERVICOM MEDICAL (SINGAPORE) PTE LTD., Visunex Medical Systems, Inc., IBM, Remidio Innovative Solutions, System Vision SA, Allied Vision Technologies GmbH, Leica Microsystems, Canon Medical Systems, USA., Carl Zeiss Meditec AG, Intelligent Retinal Imaging Systems, Nikon Corporation, Kowa American Corporation, Topcon Europe Medical BV, NextSight, Veatch Ophthalmic Instruments, Boston Micromachines Corporation, Thales Group and Imagine Eyes.
The various market players in the new born eye imaging systems market are looming with advanced devices and technologies for imaging purposes as well as raising funds for research activities which are also largely contributing to the growth in the global market over the forecast period of 2022 to 2032.
Some of the key developments in the new born eye imaging systems market are :
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 5.7% from 2022 to 2032 |
Base Year for Estimation | 2021 |
Historical Data | 2016 to 2021 |
Forecast Period | 2022 to 2032 |
Quantitative Units | Revenue in USD million and CAGR from 2022-2032 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
The growth outlook for the new born eye imaging systems market is predicted to advance at a CAGR of 5.7% from 2022-to 2032.
The North American region is anticipated to lead the new born eye imaging systems market during the forecast period.
The new born eye imaging systems market is likely to hold a valuation of US$ 374.3 million by 2032.
The healthcare industry sector is the key driver in the new born eye imaging systems market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global New Born Eye Imaging Systems Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global New Born Eye Imaging Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Diseases Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Diseases Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Diseases Type, 2022-2032
5.3.1. Retinopathy of Prematurity
5.3.2. Ocular Development
5.3.3. Refractive State
5.3.4. Strabismus
5.3.5. Visual Functions
5.3.6. Visual Acuity
5.3.7. Visual Fields
5.3.8. Colour Vision
5.4. Y-o-Y Growth Trend Analysis By Diseases Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Diseases Type, 2022-2032
6. Global New Born Eye Imaging Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Device Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Device Type, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Device Type, 2022-2032
6.3.1. Basic Device
6.3.2. Wireless Device
6.4. Y-o-Y Growth Trend Analysis By Device Type, 2017-2021
6.5. Absolute $ Opportunity Analysis By Device Type, 2022-2032
7. Global New Born Eye Imaging Systems Market Analysis 2017-2021 and Forecast 2022-2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
7.3.1. Hospital
7.3.2. Ophthalmology Diagnosis Centre
7.3.3. Ambulatory Surgical Centre
7.3.4. Others
7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
8. Global New Born Eye Imaging Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America New Born Eye Imaging Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Diseases Type
9.2.3. By Device Type
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Diseases Type
9.3.3. By Device Type
9.3.4. By End User
9.4. Key Takeaways
10. Latin America New Born Eye Imaging Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Diseases Type
10.2.3. By Device Type
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Diseases Type
10.3.3. By Device Type
10.3.4. By End User
10.4. Key Takeaways
11. Europe New Born Eye Imaging Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Diseases Type
11.2.3. By Device Type
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Diseases Type
11.3.3. By Device Type
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific New Born Eye Imaging Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Malaysia
12.2.1.5. Singapore
12.2.1.6. Australia
12.2.1.7. New Zealand
12.2.1.8. Rest of APAC
12.2.2. By Diseases Type
12.2.3. By Device Type
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Diseases Type
12.3.3. By Device Type
12.3.4. By End User
12.4. Key Takeaways
13. MEA New Born Eye Imaging Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Diseases Type
13.2.3. By Device Type
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Diseases Type
13.3.3. By Device Type
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries New Born Eye Imaging Systems Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Diseases Type
14.1.2.2. By Device Type
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Diseases Type
14.2.2.2. By Device Type
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Diseases Type
14.3.2.2. By Device Type
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Diseases Type
14.4.2.2. By Device Type
14.4.2.3. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Diseases Type
14.5.2.2. By Device Type
14.5.2.3. By End User
14.6. U.K.
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Diseases Type
14.6.2.2. By Device Type
14.6.2.3. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Diseases Type
14.7.2.2. By Device Type
14.7.2.3. By End User
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Diseases Type
14.8.2.2. By Device Type
14.8.2.3. By End User
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Diseases Type
14.9.2.2. By Device Type
14.9.2.3. By End User
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Diseases Type
14.10.2.2. By Device Type
14.10.2.3. By End User
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Diseases Type
14.11.2.2. By Device Type
14.11.2.3. By End User
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Diseases Type
14.12.2.2. By Device Type
14.12.2.3. By End User
14.13. Malaysia
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Diseases Type
14.13.2.2. By Device Type
14.13.2.3. By End User
14.14. Singapore
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Diseases Type
14.14.2.2. By Device Type
14.14.2.3. By End User
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Diseases Type
14.15.2.2. By Device Type
14.15.2.3. By End User
14.16. New Zealand
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Diseases Type
14.16.2.2. By Device Type
14.16.2.3. By End User
14.17. GCC Countries
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Diseases Type
14.17.2.2. By Device Type
14.17.2.3. By End User
14.18. South Africa
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Diseases Type
14.18.2.2. By Device Type
14.18.2.3. By End User
14.19. Israel
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Diseases Type
14.19.2.2. By Device Type
14.19.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Diseases Type
15.3.3. By Device Type
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Visunex Medical Systems, Inc.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Eye Photo Systems
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Merge Healthcare Incorporated
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. D-EYE S.r.l.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Imagine Eyes
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Natus Medical Incorporated
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Servicom Medical (Singapore) Pte Ltd.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports